Contrast-enhanced MRI of focal liver tumors using a hepatobiliary MR contrast agent: Detection and differential diagnosis using Gd-EOB-DTPA-enhanced versus Gd-DTPA-enhanced MRI in the same patient

Academic Radiology

Volumn 9, Issue SUPPL. 1, 2002, Pages

  Hammerstingl, Renate ^a   Zangos, Stephan ^a   Schwarz, Wolfram ^a   Rosen, Thomas ^a   Bechstein, Wolf Otto ^b   Balzer, Thomas ^c   Vogl, Thomas J ^a  

^a GOETHE UNIVERSITY   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; GADOXETIC ACID;

CANCER DIAGNOSIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; HEPATOBILIARY RADIOGRAPHY; HUMAN; HUMAN TISSUE; LIVER TUMOR; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL;

EID: 0036232612     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1076-6332(03)80415-4     Document Type: Conference Paper

References (0)